| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2757 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 MVM Zhang, Qiana, Liu Zhiyonga Science 370 (6515), eabd4570, 2020 | 2361 | 2020 |
| Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Gisen Group The Lancet 349 (9069), 1857-1863, 1997 | 1578 | 1997 |
| Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria P Ruggenenti, A Perna, G Gherardi, G Garini, C Zoccali, M Salvadori, ... The Lancet 354 (9176), 359-364, 1999 | 1183 | 1999 |
| The pathophysiology of IgA nephropathy H Suzuki, K Kiryluk, J Novak, Z Moldoveanu, AB Herr, MB Renfrow, ... Journal of the American Society of Nephrology 22 (10), 1795-1803, 2011 | 945 | 2011 |
| Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy P Toniati, S Piva, M Cattalini, E Garrafa, F Regola, F Castelli, ... Autoimmunity reviews 19 (7), 102568, 2020 | 878 | 2020 |
| Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial G Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G Lancet 352 (9136), 1252-1256, 1998 | 792 | 1998 |
| Genome-wide association study identifies susceptibility loci for IgA nephropathy AG Gharavi, K Kiryluk, M Choi, Y Li, P Hou, J Xie, S Sanna-Cherchi, ... Nature genetics 43 (4), 321-327, 2011 | 709 | 2011 |
| Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens K Kiryluk, Y Li, F Scolari, S Sanna-Cherchi, M Choi, M Verbitsky, D Fasel, ... Nature genetics 46 (11), 1187-1196, 2014 | 678 | 2014 |
| Tolvaptan in later-stage autosomal dominant polycystic kidney disease VE Torres, AB Chapman, O Devuyst, RT Gansevoort, RD Perrone, G Koch, ... New England Journal of Medicine 377 (20), 1930-1942, 2017 | 650 | 2017 |
| Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths VT Bastard P, Gervais A Science Immunology 6 (6219), eabl4340, 2021 | 544 | 2021 |
| A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. C Ponticelli, P Altieri, F Scolari, P Passerini, D Roccatello, B Cesana, ... Journal of the American Society of Nephrology 9 (3), 444-450, 1998 | 538 | 1998 |
| Renal outcome in patients with congenital anomalies of the kidney and urinary tract S Sanna-Cherchi, P Ravani, V Corbani, S Parodi, R Haupt, G Piaggio, ... Kidney international 76 (5), 528-533, 2009 | 474 | 2009 |
| IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 AG Gharavi, Y Yan, F Scolari, FP Schena, GM Frasca, GM Ghiggeri, ... Nature genetics 26 (3), 354-357, 2000 | 456 | 2000 |
| A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia F Alberici, E Delbarba, C Manenti, L Econimo, F Valerio, A Pola, C Maffei, ... Kidney international 97 (6), 1083-1088, 2020 | 437 | 2020 |
| Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis K Kiryluk, Y Li, S Sanna-Cherchi, M Rohanizadegan, H Suzuki, F Eitner, ... PLoS genetics 8 (6), e1002765, 2012 | 417 | 2012 |
| Identification of the gene for oral-facial-digital type I syndrome MI Ferrante, SA Feather, A Bulfone, V Wright, M Ghiani, A Selicorni, ... The American Journal of Human Genetics 68 (3), 569-576, 2001 | 398 | 2001 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 389 | 2021 |
| Cholesterol crystal embolism: a recognizable cause of renal disease F Scolari, R Tardanico, R Zani, A Pola, BF Viola, E Movilli, R Maiorca American Journal of Kidney Diseases 36 (6), 1089-1109, 2000 | 381 | 2000 |
| Clinical and morphological features of kidney involvement in primary Sjögren's syndrome N Bossini, S Savoldi, F Franceschini, S Mombelloni, M Baronio, ... Nephrology Dialysis Transplantation 16 (12), 2328-2336, 2001 | 348 | 2001 |
Gian Marco GhiggeriU.O.C. Nefrologia, Dialisi e Trapianto, Istituto Giannina GasliniAdresă de e-mail confirmată pe ospedale-gaslini.ge.it
